We all want to save money, and often, that boils down to being frugal with the things we buy. But while it pays to cut corners in certain areas of your life, there are some expenses that are actually worth paying a premium for. Here are a few instances where being cheap might actually cost you in the long run.
1. Health insuranceHealth insurance can be a budget-busting expense, but buying a low-cost plan isn't necessarily the ticket to saving money. Quite the contrary: Premiums and deductibles tend to have an inverse relationship so that the less you spend on the former, the more you inevitably wind up spending on the latter. And that, in turn, could end up costing you more money over the course of a given year.
Image source: Getty Images.
Another thing to keep in mind is that costlier health insurance often translates into better coverage, which can save you money on copays and other out-of-pocket expenses. So before you opt for the plan with the lowest premium, shop around and see what different price points buy you.
Top 5 Performing Stocks To Buy Right Now: Microvision Inc.(MVIS)
MicroVision, Inc. engages in the development of miniature laser display and imaging engines based upon its proprietary PicoP display engine technology. Its technology uses two dimensional micro-electrical mechanical systems, lasers, optics, and electronics to create a video or still image from a small form factor device. The company offers Pico projector displays intended to be used for users of mobile consumer devices, such as smartphones, media players, tablet PCs, and other consumer electronics products. Its products also comprise automotive head-up displays that project high-resolution images onto the windshield of an automobile providing the driver with information consisting of GPS mapping images, audio controls, and other automobile instrumentation information related to the car's operation. In addition, the company offers near-eye wearable display platform to provide personal viewing of information from a mobile device through a wired or wireless connection. Furthe r, it offers ROV hand held bar code scanners, and bar code scanner enabled enterprise solutions through distributors and original equipment manufacturers, as well as directly to end users through its online store. The company serves customers operating in the consumer, defense, industrial, and medical markets. MicroVision, Inc. was founded in 1993 and is headquartered in Redmond, Washington.
Advisors' Opinion:- [By Shane Hupp]
Get a free copy of the Zacks research report on Microvision (MVIS)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Ethan Ryder]
Get a free copy of the Zacks research report on Microvision (MVIS)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Top 5 Performing Stocks To Buy Right Now: PNC Financial Services Group, Inc. (PNC)
Headquartered in Pittsburgh, Pennsylvania, we are one of the largest diversified financial services companies in the United States. We have businesses engaged in retail banking, corporate and institutional banking, asset management, and residential mortgage banking, providing many of our products and services nationally, as well as other products and services in our primary geographic markets located in Pennsylvania, Ohio, New Jersey, Michigan, Illinois, Maryland, Indiana, Florida, North Carolina, Kentucky, Washington, D.C., Delaware, Virginia, Alabama, Georgia, Missouri, Wisconsin and South Carolina. We also provide certain products and services internationally. At December 31, 2015, our consolidated total assets, total deposits and total shareholders' equity were $358.5 billion, $249.0 billion and $44.7 billion, respectively. Advisors' Opinion:
- [By Garrett Baldwin]
See Now: Our founder just released his No. 1 pick for 2019. Don't miss this. See the urgent briefing here…
Walt Disney Co. (NYSE: DIS) unveiled its highly anticipated streaming service on Thursday. The service, Disney+, will launch Nov. 12 and cost $6.99 per month or $69 per year. The service will include television shows and films from its extended universe of programming – including the Star Wars and Marvel series. Disney said that all of its new films will be available on the service as soon as their theatrical windows have ended. In merger news, Chevron Corp. (NYSE: CVX) announced plans to purchase Anadarko Petroleum Corp. (NYSE: APC) as the oil major continues to push into the U.S. shale business. Shares of APC popped 32% in pre-market hours after Chevron announced the $33 billion bid. This is the largest energy merger since 2016 after Royal Dutch Shell Plc. (NYSE: RDS.A) purchased BG Group. The news sent shares of companies that operate in the Permian basin in West Texas even higher this morning. Look for other earnings reports from PNC Financial Services Group Inc. (NYSE: PNC) and Infosys Ltd. (NASDAQ: INFY). This Is How You Can Grow Incredibly Rich Buying Straight-Up StocksRight now, even with all the market uncertainty, there's truly a ridiculous amount of money to be made from stocks if you follow this secret.
- [By Money Morning Staff Reports]
Buffett is no stranger to banks. He's owned a piece of Wells Fargo & Co. (NYSE: WFC) for 19 years. And recently, he took some big chunks of some of the other big and well-known banks, including Bank of America Corp. (NYSE: BAC), Goldman Sachs Group Inc. (NYSE: GS), Bank of New York Mellon Corp. (NYSE: BK), and PNC Financial Services Group Inc. (NYSE: PNC).
- [By Motley Fool Transcribers]
PNC Financial Services Group Inc (NYSE:PNC)Q1 2019 Earnings CallApril 12, 2019, 9:30 a.m. ET
Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:Operator
- [By Eric Volkman]
In 2015, it forged a partnership with one of the "big four" nationwide banks, JPMorgan Chase (NYSE:JPM). On Deck's small-business loan software platform is being used by JPMorgan Chase to service some of the big bank's clients in that demographic. On Deck struck a similar deal with regional lender PNC Financial Services (NYSE:PNC) last October.
Top 5 Performing Stocks To Buy Right Now: Nortek Inc.(NTK)
NetScientific plc is a transatlantic healthcare technology company. The Company develops and manages early/mid-stage healthcare technology companies sourced from strategic partnerships and relationships in the United States and Europe with a primary focus on diagnostics, digital health and therapeutics. The Company is engaged in the development of intellectual property. Its portfolio consists of WANDA Health, an analytics company that uses machine learning to derive a personalized risk score for Congestive Heart Failure patients; Glucosense, a provider of a non-invasive glucose monitoring wearable device; Vortex Biosciences, which is engaged in circulating tumor cell identification, selection and analysis for disease monitoring and personalized therapeutic prescribing; Glycotest, which provides non-invasive blood tests for liver cancers and fibrosis-cirrhosis, and ProAxsis, which is engaged in respiratory disease diagnosis and treatment monitoring. Advisors' Opinion:- [By Shane Hupp]
NetKoin (NTK) is a token. It was first traded on January 7th, 2018. NetKoin’s total supply is 7,853,060,094 tokens and its circulating supply is 3,976,070,194 tokens. NetKoin’s official website is www.netkoin.com. NetKoin’s official Twitter account is @netkoin and its Facebook page is accessible here.
- [By Logan Wallace]
Neurotoken (CURRENCY:NTK) traded down 8.5% against the dollar during the 1 day period ending at 22:00 PM Eastern on September 2nd. One Neurotoken token can currently be purchased for approximately $0.0421 or 0.00000579 BTC on cryptocurrency exchanges including BCEX, YoBit, Tidex and Cobinhood. In the last seven days, Neurotoken has traded 17.7% lower against the dollar. Neurotoken has a total market capitalization of $3.41 million and approximately $211,773.00 worth of Neurotoken was traded on exchanges in the last day.
- [By Stephan Byrd]
NetKoin (NTK) is a token. Its genesis date was January 7th, 2018. NetKoin’s total supply is 99,508,709,867 tokens. The official website for NetKoin is www.netkoin.com. NetKoin’s official Twitter account is @netkoin and its Facebook page is accessible here.
- [By Stephan Byrd]
News articles about Nortek (NASDAQ:NTK) have been trending somewhat positive recently, according to Accern Sentiment Analysis. Accern identifies positive and negative press coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Nortek earned a coverage optimism score of 0.21 on Accern’s scale. Accern also gave media stories about the construction company an impact score of 47.207131440996 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the near term.
Top 5 Performing Stocks To Buy Right Now: Genomic Health, Inc.(GHDX)
Genomic Health, Inc., incorporated on August 22, 2000, is a healthcare company, which provides genomic-based diagnostic tests for the treatment of early stage cancer. The Company offers its Oncotype DX tests as a clinical laboratory service, where it analyzes the expression levels of genes in tumor tissue samples and provides physicians with a quantitative gene expression profile expressed as a single quantitative score, which it calls a Recurrence Score for invasive breast cancer and colon cancer, a DCIS Score for ductal carcinoma in situ (DCIS) and a Genomic Prostate Score (GPS) for prostate cancer.
The Company's Oncotype DX tests analyze the expression levels of various genes across various biological pathways. Its offerings also include Oncotype DX Breast Cancer Test, Oncotype DX Colon Cancer Test and Oncotype DX Prostate Cancer Test. The Oncotype DX breast, colon and prostate cancer tests analyze various genes and are based on its Oncotype DX RT-PCR platform. The Company offers its services and products through its Oncotype IQ Genomic Intelligence Platform. Its Oncotype IQ Genomic Intelligence Platform product pipeline also includes products for tumor monitoring under its Oncotype TRACK for various cancer types. The Company offers its testing services through its clinical reference laboratory located in Redwood City.
Oncotype DX Tests
The Company's Oncotype DX tests utilize quantitative genomic analysis known as reverse transcription polymerase chain reaction (RT-PCR), in standard tumor pathology specimens to provide tumor-specific information, or the oncotype of a tumor. Its diagnostic approach correlates gene expression to clinical outcomes and provides an individualized analysis of each patient's tumor. The Company's technologies allow it to analyze tumor tissue samples in its clinical reference laboratory and provide physicians with genomic information specific to the patient's tumor. The Company analyzes tissues that are handled, processed and stored un! der routine clinical pathology laboratory practices.
The Company competes with Roche Holding, Ltd, Siemens AG, Guardant Health, Johnson & Johnson, NanoString Technologies Inc., BioTheranostics, Sividon Diagnostics, Myriad Genetics Inc., NeoGenomics Laboratories, GenomeDx Biosciences Inc., Agendia Inc., Hologic Inc., Novartis AG, Qiagen N.V., Foundation Medicine, Grail, MDxHealth, Natera Inc., Trovagene Inc., Laboratory Corporation of America Holdings and Quest Diagnostics Incorporated.
Advisors' Opinion:- [By Shane Hupp]
Genomic Health (NASDAQ:GHDX) was downgraded by investment analysts at ValuEngine from a “strong-buy” rating to a “buy” rating in a note issued to investors on Tuesday.
- [By Maxx Chatsko]
Despite all the progress, Invitae is still the least mature business among its publicly traded peers, including Genomic Health (NASDAQ:GHDX) and Myriad Genetics (NASDAQ:MYGN). Here's how it compares to its closest competitors:
- [By Motley Fool Transcription]
Genomic Health, Inc. (NASDAQ:GHDX) Q4 2018 Earnings Conference Call February 20, 2019, 4:30 p.m. ET
Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:Operator
Top 5 Performing Stocks To Buy Right Now: Eaton Vance Municipal Income 2028 Term Trust(ETX )
Eaton Vance Municipal Income 2028 Term Trust (formerly, Eaton Vance Municipal Income Term Trust) (the Trust) is a diversified, closed-end management investment company. The Trust's investment objective is to provide current income exempt from regular federal income tax. The Trust's portfolio of investments include education, electric utilities, general obligations, hospital, housing, industrial development, senior living or life care, student loan, transportation, water and sewer, among others. The Fund's investment adviser is Eaton Vance Management. Advisors' Opinion:- [By Max Byerly]
Etrion SA (TSE:ETX) – Equities researchers at National Bank Financial issued their Q4 2018 earnings estimates for shares of Etrion in a research note issued on Thursday, August 9th. National Bank Financial analyst R. Merer expects that the solar energy provider will post earnings of ($0.01) per share for the quarter. National Bank Financial also issued estimates for Etrion’s FY2019 earnings at ($0.01) EPS.
No comments:
Post a Comment